Group One Trading, L.P. Avrobio, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.22 - $1.62 $15 - $21	13 New	13 $0
Q1 2022 May 12, 2022	SELL	$1.29 - $4.04 $645 - $2,020	-500 Reduced 14.26%	3,007 $4,000
Q3 2021 Nov 12, 2021	SELL	$5.53 - $9.28 $116,130 - $194,880	-21,000 Reduced 85.69%	3,507 $20,000
Q2 2021 Aug 10, 2021	SELL	$7.84 - $12.6 $27,126 - $43,596	-3,460 Reduced 12.37%	24,507 $218,000
Q1 2021 May 12, 2021	BUY	$10.54 - $19.3 $294,772 - $539,763	27,967 New	27,967 $355,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.